|
TRIM27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.659600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.892800E-01 |
| Normal-vs-Stage2 |
5.050600E-01 |
| Normal-vs-Stage3 |
8.789900E-02 |
| Normal-vs-Stage4 |
3.742400E-01 |
| Stage1-vs-Stage2 |
6.533000E-01 |
| Stage1-vs-Stage3 |
1.520620E-01 |
| Stage1-vs-Stage4 |
4.730800E-01 |
| Stage2-vs-Stage3 |
4.423200E-01 |
| Stage2-vs-Stage4 |
7.969400E-01 |
| Stage3-vs-Stage4 |
6.973600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.903980E-01 |
| Normal-vs-AfricanAmerican |
1.255820E-01 |
| Normal-vs-Asian |
3.217000E-01 |
| Caucasian-vs-AfricanAmerican |
6.089800E-01 |
| Caucasian-vs-Asian |
3.918200E-01 |
| AfricanAmerican-vs-Asian |
4.628600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.763400E-01 |
| Normal-vs-Female |
2.951600E-02 |
| Male-vs-Female |
9.317800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.564000E-01 |
| Normal-vs-Extreme_Weight |
8.966800E-01 |
| Normal-vs-Obese |
4.493600E-02 |
| Normal-vs-Extreme_Obese |
7.751000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.315600E-01 |
| Normal_Weight-vs-Obese |
3.675200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.937200E-01 |
| Extreme_Weight-vs-Obese |
5.978000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.029800E-01 |
| Obese-vs-Extreme_Obese |
2.688400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.077410E-03 |
| Normal-vs-Age(41-60Yrs) |
2.728300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.789000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.811900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.656620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.531700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.481920E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.772430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.624000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.440500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.019900E-02 |
| Normal-VS-Type2 PRCC |
9.240800E-01 |
| Normal-VS-KIRP CIMP |
4.471400E-01 |
| Normal-VS-Unclassified PRCC |
5.898800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.262300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.837200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.384400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.381200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.984000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.331600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.960400E-01 |
| Normal-vs-N1 |
1.056100E-02 |
| Normal-vs-N2 |
1.075570E-02 |
| N0-vs-N1 |
1.044430E-02 |
| N0-vs-N2 |
8.450300E-02 |
| N1-vs-N2 |
3.562000E-02 |
|
|
